Latest Financial Performance News

IVE Group Limited reported a 69% jump in net profit for FY25 despite a slight revenue dip, driven by margin expansion and operational efficiencies. The company maintains a strong balance sheet and outlines ambitious growth and sustainability plans for FY26.

Intelligent Monitoring Group reports robust FY2025 financials, completes a strategic acquisition, and issues new shares following warrant exercises, signaling a confident growth trajectory.

G8 Education reported a 3.7% revenue decline but a 12.4% rise in net profit for the first half of 2025, amid ongoing cost-of-living challenges impacting occupancy. The company declared a dividend and announced a share buyback, underscoring confidence despite sector headwinds.

G8 Education Limited reported a moderate earnings improvement for the half year ended June 2025 despite ongoing occupancy challenges and regulatory uncertainty. The company is intensifying child safety measures following a Victorian incident and plans a share buy-back to enhance shareholder value.

G8 Education Limited reported a 12.4% rise in net profit to $22.5 million for the first half of 2025, navigating lower occupancy and divestments with strategic cost controls and capital management.

Tribeca Global Natural Resources Limited has reversed last year’s loss to report a $5 million profit and declared a fully franked dividend, while unveiling a significant share buyback program to address its discount to net tangible assets.

Mader Group Limited has reported a solid 13% increase in both revenue and profit for the 2025 financial year, accompanied by a notable rise in dividends.

Australian Clinical Labs delivered solid FY25 financial results with revenue up 6.4% and EBIT rising 8.7%, underpinned by operational efficiencies and strategic innovation. The company’s FY26 guidance signals continued growth amid evolving market conditions and government fee pressures.

Australian Clinical Labs reported robust FY25 financial results with revenue and earnings growth, alongside a strong dividend payout and positive outlook for FY26.

Australian Clinical Labs reported a 6.4% revenue increase and an 8.7% rise in underlying EBIT for FY25, maintaining disciplined growth and operational efficiency in a complex healthcare environment.

Fortescue Metals Group reported a robust FY25 with record iron ore shipments and strong profits, while advancing its green metal and decarbonisation initiatives. The company also provided solid FY26 guidance amid ongoing exploration and capital discipline.

Fortescue Metals Group reported a solid US$3.4 billion net profit for FY25, driven by record iron ore shipments and a strong balance sheet, while advancing ambitious decarbonisation and green energy projects.